Department of Neurobiology, University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania
 |
Introduction |
N-Methyl-D-aspartate
(NMDA) receptor activation has been linked to many important cellular
processes in the brain, including neuronal development, synaptic
plasticity and excitotoxic cell death (Michaelis, 1998
). It is
therefore not surprising that the function of the NMDA receptor itself
is tightly regulated by a variety of endogenous factors such as
magnesium, protons, polyamines, and zinc (McBain and Mayer, 1994
;
Dingledine et al., 1999
). Redox-active agents can also modify NMDA
receptor activity, with reducing agents potentiating the response to
NMDA, and oxidizing agents reversing the actions of reductants and
sometimes attenuating the response to the agonist (Aizenman et al.,
1989
; Tang and Aizenman, 1993a
). A physiological role for this
modulatory site was suggested following the discovery of a number of
redox-active substances of endogenous origin, which could alter the
redox state of the receptor in dissociated mammalian neurons (Aizenman,
1994
; Sinor et al., 1997
). In fact, alteration of the redox site by
endogenously derived factors has been associated with certain forms of
long-term potentiation and long-term depression in hippocampal slices
(Gozlan et al., 1995
). The redox-active substances responsible for
these effects in more intact brain tissue remain to be identified.
In recombinant receptors, two separate redox sites on the NMDA receptor
have been proposed to exist, each on separate subunits. Using
site-directed mutagenesis, Sullivan et al. (1994)
determined that two
cysteines on the NMDA receptor subunit (NR) 1, Cys744 and Cys798, were
largely responsible for redox modulation of receptors composed of
NR1/NR2B, NR1/NR2C, or NR1/NR2D subunit combinations. As the
sensitivity of NR1/NR2A receptors to thiol agents was only slightly
diminished when these two cysteine residues were mutated, an additional
redox site, unique to NR1/NR2A receptors, was suggested. Using chimeric
constructs, Köhr et al. (1994)
concluded that the amino terminus
of the NR2A subunit contained such site. However, to date, the amino
acid residues constituting the redox site on NR2A have not been
identified. Mutating various cysteines located in the amino terminus of
this subunit, either individually (Sullivan et al., 1994
; Köhr et
al., 1994
), or in tandem (Choi et al., 1997
), does not totally abolish
the redox sensitivity of NR2A-containing receptors. Although the
existence of a separate redox site on NR2A has been questioned
(Paoletti et al., 1997
), the recent discovery of an NR2A-selective
reducing agent strongly argues for the presence of such a site (Arden
et al., 1998
).
Single-channel studies have revealed that reducing agents potentiate
NMDA-induced responses of NR1/NR2A receptors by increasing both the
open dwell-time of the channel and increasing the frequency of channel
opening relative to the oxidized state (Brimecombe et al., 1997
). A
sulfhydryl agent-induced alteration in NR1/NR2B- or NR1/NR2C-mediated
channel activity, however, is manifested only as a change in opening
frequency (Brimecombe et al., 1997
). The present study attempted to
determine whether the two proposed redox sites on NR1 and on NR2A could
act independently of each other in affecting channel function. Because
only NR1/NR2A receptors display an increase in open dwell-time in the
presence of reductants, we hypothesized that the putative NR2A redox
site alone could affect this channel property. Furthermore, because
redox agents influence the frequency of channel opening in all receptor
configurations, and all receptors contain the NR1 subunit, we further
hypothesized that cysteines 744 and 798 of NR1 were critical for this
type of channel alteration. We have therefore determined the extent of
redox modulation of receptors composed of NR2A, NR2B, or NR2C when
coexpressed with an NR1 subunit in which Cys744 and Cys798 have been mutated.
 |
Materials and Methods |
Transfection Protocol.
Chinese hamster ovary (CHO)-K1 cells
were grown in Ham's F-12 nutrient medium with 10% fetal bovine serum
and 1 mM glutamine and passaged (<30 times) at a 1:10 dilution when
80% confluent, approximately every 2 days. The cDNAs for NR1a
(hereafter referred to simply as NR1; a gift from Dr. S. Nakanishi, Kyoto University, Kyoto, Japan), NR2A, and NR2C (gifts
from Dr. P. Seeburg, Max Planck Institute for Medical Research,
Heidelberg, Germany) were previously subcloned into a mammalian
expression vector (Boeckman and Aizenman, 1994
, 1996
). NR1(C744A,
C798A) was a kind gift from Dr. S. Traynelis, Emory University,
Atlanta, GA. The mouse clones
1 (NR2A) and
2 (NR2B) were
previously subcloned into pRK7 (Meguro et al., 1992
; Gallagher et al.,
1996
) and were generous gifts from Dr. D. Lynch, University of
Pennsylvania, Philadelphia, PA, and Dr. M. Mishina, University of
Tokyo, Tokyo, Japan. NR2A and
1 were used interchangeably. For this
study we used
2 exclusively rather than NR2B (Boeckman and Aizenman,
1996
), because functional expression of receptors with this latter
vector was unexplainably lost. Although we noted an increase in the
mean open dwell-time of NR1/
1 and NR1/
2 receptors when compared
with those previously reported for NR1/NR2A and NR1/NR2B channels
(Brimecombe et al., 1997
) all other receptor properties, including
redox sensitivity, were virtually identical between the rat and mouse
subunits. The vector for a positive transfection marker, green
fluorescent protein (pCI/GFP; a gift from Dr. M. Chalfie, Columbia
University, New York, NY), was also generated previously (Brimecombe et
al., 1997
). CHO cells were seeded at 2.5 × 105
cells/well in 6-well plates approximately 24 h before transfection with 1.3 µg of total DNA and 5 µl of lipofectAMINE (Gibco-BRL) in 1 ml of serum-free CHO media per 35-mm dish. The ratio of pCI/GFP to
total other DNA was 1:4.3, and the ratio of NR1 to NR2 was always 1:3
(Cik et al., 1993
). After a 4- to 5-h incubation at 37°C, cells
were refed with CHO medium containing 300 µM ketamine to prevent cell
death which ensues following functional receptor expression (Boeckman
and Aizenman, 1996
). Cells were used for recording 40 to 50 h
after transfection.
Patch-Clamp Recordings and Analysis.
The extracellular
solution contained: 150 mM NaCl, 2.8 mM KCl, 1.0 mM CaCl2,
10 mM HEPES, and 0.01 mM glycine 0.01, pH adjusted to 7.2 with 0.3 N
NaOH. The pipette solution contained: 14 mM CsF, 10 mM EGTA, 1.0 mM
CaCl2, and 10 mM HEPES, pH adjusted to 7.2 with CsOH.
Whole-cell measurements were performed at
60 mV with 2 M
electrodes; methods for acquisition and analysis of whole-cell data
have been described previously (Tang and Aizenman, 1993a
). NMDA (30 µM), dithiothreitol (DTT; 4 mM) and 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB; 0.5 mM) were applied to the cells by a multibarrel fast
perfusion system (Warner Instruments, Hamden, CT). Single-channel recordings were performed at
60 mV with the same recording solutions on outside-out patches using 10 to 15 M
electrodes. Drugs were applied to the patch by complete bath exchange (Brimecombe et al.,
1997
).
Outside-out patches were exposed to 1 mM DTT and 0.5 mM DTNB for
approximately 1 to 2 min for each single treatment, initiated in random
order across patches. Patches were exposed to the reductant and oxidant
repeated times, each seeing both conditions two to three times, on
average. Under each treatment, NMDA (10 µM)-activated events were
recorded and later analyzed. Unitary conductances were amplified with
an Axopatch 200 (Axon Instruments, Foster City, CA), filtered at 2 kHz,
stored on videotape, and later replayed and digitized at 10 kHz
(Digidata 1200; Axon Instruments). Single-channel analysis was
performed using pClamp6 software (Axon Instruments) using a 50%
threshold detection criteria. A large number of patches from CHO cells
positive for GFP had no NMDA channel activity. In total, data were
gathered from 17 patches obtained from approximately 20 separate
transfection experiments. Data from patches lost before the completion
of a treatment protocol were not used, because each patch served as its
own control. Normally, 200 to 500 events were analyzed per single
treatment. Amplitude histograms were most commonly fit with single
Gaussians. Most open dwell-time histograms were best fit with a single
exponential function using a simplex maximum likelihood routine on
log-transformed binned data (6 bins/decade). A
-squared test was
used to determine the simplest fit of the data. When an open dwell-time
histogram was better fit by the sum of two exponentials (e.g., see Fig.
1B), the weighted mean open time was used
for the comparison of means (Brimecombe et al., 1997
). Events briefer
than 180 µs (twice the rise time of the filter) were ignored. The
single-channel amplitude and open dwell-time values were calculated and
averaged for all similar treatments for each patch (usually
2-3/patch), and then averaged across patches. Opening frequency in
sequential DTT and DTNB treatments were used to calculate the
FDTT/FDTNB value (see Table
1) for a single patch. These were then
averaged across all patches, which are the values shown in Table 1. As
an example, one NR1(C744A, C798A)/NR2A patch had the following opening
frequency values (in events per second) DTT = 7.5, DTNB = 0.5, DTT = 5.5, DTNB = 1.6, and DTT = 19. These values
resulted in the following FDTT/FDTNB values: 15, 11, 3.4, and 11.9, which averaged 10.3. This procedure was done for all
five patches with this subunit configuration. We thought it was
important to perform several treatments per patch to determine whether
the opening frequency changed as a result of a redox treatment. A
FDTT/FDTNB ratio of 1 would
suggest no treatment effect (i.e., the null hypothesis). Results are
expressed as mean ± S.E.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Mutating Cys744 and Cys798 on the NR1 subunit does
not alter the single-channel redox properties of NR2A-containing
receptors. A, representative 10 µM NMDA-induced single channel events
from an outside-out membrane patch excised from a CHO cell transfected
with NR1(C744A, C798A)/NR2A in the continuous presence of either 1 mM
DTT or 0.1 mM DTNB. B, open dwell-time histograms for the events from
the patch represented in A. The exponential functions fitting both
distributions denote a change in time constants between the reduced
(7.5 ms) and oxidized (5.4 and 6.3 ms) conditions. C, frequency of NMDA
channel opening during the DTT and DTNB treatments for the same patch
(hence the lack of error bars). The average change in open channel
frequency between the two redox treatments
(FDTT/FDTNB) for the five patches obtained from
cells transfected with this subunit combination are shown in Table 1.
|
|
 |
Results |
Single-Channel Redox Properties of NR1-Mutated NMDA Receptors.
NMDA (10 µM)-activated channels were first recorded from patches
excised from cells transfected with the NR1(C744A, C798A)/NR2A subunit
combination (n = 5; Fig. 1A). The single-channel
amplitudes of the unitary currents mediated by these channels were not
altered by redox treatments (
3.4 ± 0.1 pA in DTT,
3.5 ± 0.1 pA in DTNB; p > .05, paired t
test). As seen in wild-type NR1/NR2A receptors (Brimecombe et al.,
1997
), the open dwell-time of the events increased significantly in the
presence of DTT when compared with DTNB (5.0 ± 0.5 ms in DTT,
3.3 ± 0.6 ms in DTNB; p < .01, paired
t test; Fig. 1B and Table 1). The mean change in open
dwell-time, which is the difference in the open time between reduced
and oxidized conditions for each patch, averaged across all patches
[
open time (OT) in Brimecombe et al., 1997
] was 1.9 ± 0.2 ms for this receptor configuration. Unexpectedly, DTT increased the
frequency of channel opening 5.0- ± 1.6-fold
(n-fold = FDTT/FDTNB, where F is opening frequency), when compared with the oxidized state (Fig. 1C
and Table 1). These values are very similar to those previously
obtained with wild-type NR1/NR2A channels (
OT = 1.6 ms,
FDTT/FDTNB = 5.7; Brimecombe et al.,
1997
). In fact, there are no significant differences in
OT or
FDTT/FDTNB between wild-type and mutant
receptors (p > .05, unpaired t tests).
The observed changes in opening frequency in NR1(C744A, C798A)/NR2A
channel seem to refute the hypothesis that the NR1 site mediates the
actions of redox agents for inducing this type of alteration of channel
properties. Therefore, we analyzed our data by a different method to
ensure that that these changes were indeed reflective of a biologically
significant phenomenon. We took advantage of the fact that untreated
control patches have consistent frequency of openings for periods of up
to at least 8 to 10 min, which is sufficient to change DTT and DTNB
treatments two to three times in a single patch (Brimecombe et al.,
1998
). We averaged all opening frequencies for a single treatment per
patch and performed a pairwise comparison. The average frequency (in
events per second) for DTNB across all NR1(C744A, C798A)/NR2A patches
(n = 5) was 9.8 ± 6.1 and 22.7 ± 8.2 for
DTT. These values are significantly different (p < .05; one-tailed paired t test). Therefore, our results
clearly indicate that redox modulation of NR1/NR2A receptors is not
dependent, to any extent, on the cysteines that form the redox site on
the NR1 subunit.
Similar to NR2A-containing channels and to wild-type NR1/NR2B receptors
(Brimecombe et al., 1997
), the single-channel amplitudes of NR1(C744A,
C798A)/NR2B-mediated events were unaffected by redox treatments
(
3.5 ± 0.1 pA in DTT,
3.4 ± 0.2 pA in DTNB;
n = 7; p > .05, paired t
test). In addition, there was no significant difference in the mean
open dwell-time of the channels between the reduced and oxidized states
(Fig. 2A and Table 1): 4.8 ± 0.6 ms
in DTT and 4.5 ± 0.6 in DTNB (p > .05, paired
t test;
OT = 0.6 ± 0.3 ms). This was not
unexpected as the open dwell-times of wild-type NR1/NR2B receptor
channels are similarly unaffected by redox treatments (
OT = 0.3 ms; Brimecombe et al., 1997
). The frequency of channel opening,
however, appeared to have been moderately increased 1.6- ± 0.5-fold in
the presence of DTT, when compared with DTNB (Fig. 2A and Table 1). In
fact, this FDTT/FDTNB value for the mutated channels is not significantly different from that previously recorded from wild-type receptors (2.0; Brimecombe et al.,
1997
; p > .05, unpaired t test). This
implies that the mutation does not affect the ability of redox agents
to modulate receptor activity. However,
FDTT/FDTNB in the mutant
channel is also not significantly different from unity
(p > .05, one sample t test), which
suggests no change in the parameter between the two treatments.
Obviously, the open-channel frequency data obtained with the NR1(C744A,
C798A)/NR2B receptors are inconclusive at this point. However, they are
suggestive of an incomplete abolition of redox sensitivity of NR1/NR2B
receptors after mutation of the redox site on NR1. This issue will be
revisited below with the whole-cell recording data.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 2.
Single channel redox properties of the
cysteine-mutated NR1 subunit coexpressed with either NR2B or NR2C. A,
open dwell-time histograms of NMDA-activated events obtained from a
representative NR1(C744A, C798A)/NR2B-containing patch (left). The open
dwell-time constants did not differ between the reduced and oxidized
conditions (4.1 and 3.9 ms, respectively). In contrast, the frequency
of channel opening was decreased in the presence of the oxidant when
compared with the open channel frequency in the presence of the
reductant (right). The average values from the seven patches obtained
from cells transfected with this receptor combination are shown in
Table 1. B, NR1(C744A, C798A)/NR2C-containing receptors were
insensitive to redox agents. There was no change in the open dwell-time
between the reduced and oxidized conditions (1.7 and 1.8 ms,
respectively; left). Furthermore, there was no change in the frequency
of channel opening between the two redox states (right). The average
values from the five patches obtained from cells expressing NR1(C744A,
C798A)/NR2C are summarized in Table 1.
|
|
Mutating cysteines 744 and 798 on the NR1 subunit appeared to be
sufficient to eliminate the redox sensitivity of NR1(C744A, C798A)/NR2C
receptors (n = 5). As observed in wild-type NR1/NR2C receptors (Brimecombe et al., 1997
), redox agents did not alter the
single-channel amplitudes (
2.1 ± 0.1 pA in DTT,
2.1 ± 0.1 pA in DTNB) or the open dwell-times of the mutated channels
(1.1 ± 0.1 ms DTT, 1.3 ± 0.1 ms DTNB,
OT =
0.1 ± 0.0 ms; Fig. 2B and Table 1). Furthermore, there was no
effect of redox agents on opening frequency in the NR1(C744A,
C798A)/NR2C subunit configuration (Fig. 2B and Table 1).
FDTT/FDTNB for NR1(C744A,
C798A)/NR2C receptors was 0.8 ± 0.1, a value not significantly
different from unity (p > .05, one sample t
test). By comparison, the frequency of channel opening in wild-type
NR1/NR2C channels was previously noted to increase 2.2-fold after
reduction (Brimecombe et al., 1997
).
Whole-Cell Measurements Suggest Presence of an Additional Redox
Site on NR2B.
NMDA (30 µM)-induced whole-cell responses were
obtained from cells transfected with NR1 or NR1(C744A, C798A) together
with either NR2A, NR2B, or NR2C. Current amplitude measurements were obtained after a 3-min incubation in 4 mM DTT and after a 1-min incubation with the oxidizing agent DTNB (0.5 mM). Mutating cysteines 744 and 798 on the NR1 subunit did not alter the extent of redox modulation of NR1/NR2A receptors (Fig.
3). The
IDTT/IDTNB peak current ratio was 3.6 ± 0.3 for wild-type NR1/NR2A receptors and 4.0 ± 0.3 for the
NR1(C744A, C798A)/NR2A subunit configuration (Table
2). These current ratios were not
significantly different from each other (p > .05, unpaired t test), and, as such, this finding indicates
that cysteines 744 and 798 are not required for the redox modulation of
NR1/NR2A receptors, similar to what the single-channel data revealed.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
Redox modulation of whole-cell currents mediated by
NR2A-containing receptors. A, representative whole-cell responses
recorded from a CHO cell expressing wild-type NR1/NR2A receptors during
application of 30 µM NMDA. Currents were measured during control
conditions, following a 3-min incubation with 4 mM DTT and after a
1-min incubation with 0.5 mM DTNB. B, similar measurements were
obtained from another CHO cell transfected with NR1(C744A, C798A)/NR2A
subunits. Responses were obtained from a total seven cells transfected
with the wild-type NR1, and from five cells transfected with the
cysteine mutated subunit. Peak current amplitudes from traces such as
these ones were used to obtained the values shown in Table 2.
|
|
Sullivan et al. (1994)
reported that mutating cysteines 744 and 798 on
the NR1 subunit rendered responses mediated by NR1/NR2B receptors
insensitive to potentiation by DTT. Our results suggest that, in fact,
NR1(C744A, C798A)/NR2B receptors are slightly redox-sensitive. Whole-cell current amplitudes obtained from cells transfected with the
subunit combination revealed that there was no significant potentiation
of NMDA-induced responses following a 3-min DTT treatment, at least
when compared with the initial, control responses in chemically naive
cells (Fig. 4). This is in contrast to
what is seen in wild-type NR1/NR2B-transfected cells, as well as in
cells expressing wild-type NR1/NR2A, NR1/NR2C channels, or mutated
NR1(C744A, C798A)/NR2A channels (Table 2). Nonetheless, we noted that
currents mediated by NR1(C744A, C798A)/NR2B were depressed by DTNB in a DTT-reversible fashion (Fig. 4). The
IDTT/IDTNB peak current
ratio for this receptor configuration was 1.4 ± 0.1 (Table 2).
This ratio value is significantly different from unity
(p < .01, one sample t test), implying that
this subunit combination is redox sensitive. Yet, this
IDTT/IDTNB ratio was also
significantly different from the
IDTT/IDTNB ratio of
wild-type NR1/NR2B receptors (4.8 ± 0.9; p < .01, unpaired t test). Therefore, as suggested earlier, mutating cysteines 744 and 798 of NR1 diminishes, but does not abolish,
the redox sensitivity of NR1/NR2B receptors.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 4.
Residual redox sensitivity of NR1(C744A, C798A)/NR2B
receptors. A, representative whole-cell responses recorded from a CHO
cell expressing NR1/NR2B receptors during application of 30 µM NMDA.
Currents were measured during control conditions, following a 3-min
incubation with 4 mM DTT and after a 1-min treatment with 0.5 mM DTNB.
Similar measurements were obtained in six additional cells. B,
responses obtained from a CHO cell transfected with NR1(C744A,
C798A)/NR2B subunits. Note that although the DTT treatment does not
substantially enhance the amplitude of the control current, DTNB
depresses the response in a DTT-reversible fashion. Similar recordings
were obtained in total of five cells transfected with this subunit
configuration. Data are summarized in Table 2.
|
|
Whole-cell recordings confirmed the finding that mutating cysteines 744 and 798 on the NR1 subunit completely abolished the redox sensitivity
of NR1/NR2C. Whereas wild-type NR1/NR2C receptors had a
IDTT/IDTNB ratio of
3.6 ± 0.4, NR1(C744A, C798A)/NR2C receptors had a
IDTT/IDTNB ratio of
1.1 ± 0.1 (Table 2). These two values were significantly
different from each other (p < .01, unpaired t test). Furthermore, the
IDTT/IDTNB ratio of
NR1(C744A, C798A)/NR2C receptors was not significantly different
from unity (p > .05, one sample t test).
Thus, cysteines 744 and 798 are necess-ary and sufficient for
full redox modulation of NR1/NR2Creceptors.
 |
Discussion |
The experiments presented here were aimed at determining the
functional effects of thiol modification of two putative redox sites on
the NMDA receptor. We have observed that Cys744 and Cys798 in the NR1
subunit are critical for redox modulation of NR2C-containing receptors,
and that these residues contribute to some, but not all, of the redox
sensitivity of the NR1/NR2B subunit combination. These findings
are mostly in agreement with the results of Sullivan et al.
(1994)
, although the residual redox sensitivity of NR1(C744A, C798B)/NR2B receptors had not been reported previously and is suggestive of yet an additional redox site on NR2B. The most surprising result obtained in the present study, however, is that the redox site
on NR1 appears not to contribute to the actions of DTT and DTNB on
NR1/NR2A receptor function, at least within the parameters examined here.
Evidence suggesting a redox sensitive in the extracellular amino
terminus of NR2A was obtained by Köhr et al. (1994)
using chimeric subunits. In that study, it was shown that the redox properties of NR1/NR2A receptors were substantially different from
those observed in all other receptor configurations tested (NR1/NR2B,
NR1/NR2C, NR1/NR2D). First, although the effects of DTT on whole-cell
currents mediated by all other subunits combinations were relatively
slow to develop (minutes), NR1/NR2A responses were enhanced very
quickly (seconds) after exposure to the reducing agent. This rapid
effect of DTT on NR1/NR2A was followed by a subsequent slow rise in
current amplitude with a time course reminiscent of the effects of this
substance on the other subunit configurations. Second, the actions of
the reductant on NR1/NR2B, NR1/NR2C, and NR1/NR2D receptors were very
long-lasting and only fully reversible following treatment with DTNB.
In contrast, the rapid current-enhancing actions of DTT on NR1/NR2A
receptors were also quick to reverse, leaving behind a DTNB-sensitive,
more persistent component, which, again, was very similar to what was
observed with the other receptors. The rapidly reversibly DTT effect on
NR1/NR2A was abolished in receptors composed of a NR2A chimeric
construct in which the amino terminus of the latter subunit was
substituted for the analogous segment of NR2C (NR2[CA]). This
suggested to the authors that an NR2A redox-sensitive site was
localized to this region. Third, all receptor configurations, except
for NR1/NR2A, could be permanently potentiated (that is, be rendered
insensitive to subsequent DTNB oxidation) when treatment with an
alkylating agent immediately followed the DTT exposure. Alkylation has
also been produced in native neuronal receptors (Tang and Aizenman,
1993a
), and it has been a useful tool for establishing redox
modulation as the mechanism of action of endogenous redox-active
substances (Aizenman et al., 1992
; Tang and Aizenman, 1993b
). Whether
alkylation can be produced in an NR1/NR2[CA] receptor remains to
be established.
Paoletti et al. (1997)
recently suggested that some of the effect of
DTT on NR1/NR2A-mediated currents are due to zinc chelation by the
reductant itself, with the ensuing removal of a high-affinity tonic
receptor block by background contamination levels of this metal. These
investigators demonstrated that rapid potentiating effects of DTT were
indistinguishable from those produced by more conventional metal
chelators. Hence, the authors concluded that the amino terminus of NR2A
likely contained a Zn2+-sensitive site, rather
than a true redox-sensitive site. Yet, in spite of these findings,
there are two lines of evidence that still favor the existence of a
unique redox site on NR2A. One, mutation of Cys744 and Cys798 in NR1,
dramatically reduces the affinity of NR1/NR2A receptors for zinc (Zheng
et al., 1998
; Traynelis et al., 1998
). In fact, Zheng et al. (1998)
observed virtually no potentiation of NR1(C744A, C798A)/NR2A responses
with concentrations of a metal chelator that were very effective in
enhancing NR1/NR2A-mediated currents. As is evident in the present
report, the effects of DTT on wild-type and mutant NR2A-containing
receptors are essentially indistinguishable. Second, recent experiments
conducted in our laboratory (Arden et al., 1998
) demonstrated that
cyanide can selectively potentiate NMDA-induced currents mediated by
NR1/NR2A receptors. The cyanide-induced current enhancement occurred
slowly (minutes) and was readily reversible by DTNB. Mutation of Cys744 of NR1 alone, sufficient to abolish DTT potentiation in NR1/NR2B receptors (Sullivan et al., 1994
), and decrease high-affinity zinc
block in NR1/NR2A (Traynelis et al., 1998
), did not block the actions
of cyanide or DTT on NR2A-containing receptors. Interestingly, the
mitochondrial poison depressed NR1/NR2B-mediated currents, reinforcing the notion that the redox sensitivity of NR1/NR2A is indeed
unique. Finally, cyanide was able to potentiate NR1/NR2A responses in
the presence of a metal chelator. It is noteworthy that in our
laboratory we have not reliably seen potentiation by zinc chelators in
wild-type NR1/NR2A receptors (Arden et al., 1998
). This likely
indicates low background levels of contaminating metals in our
solutions, or that endogenous tyrosine kinase Src activity is high in
CHO cells, as NMDA receptor phosphorylation by this enzyme reduces
tonic zinc inhibition in NR1/NR2A receptor channels (Zheng et al.,
1998
). The fact that NR1/NR2A receptors cannot be alkylated (Köhr
et al., 1994
) is further suggestive that the redox site on NR1 does not
mediate the effects of thiol substances on this subunit combination.
The single-channel experiments in the present investigations were
initially designed to test the hypothesis that the redox-sensitive site
on NR1 would influence the frequency of channel opening and that the
NR2A redox site would modify the open dwell-time of the channel.
Namely, we were interested in investigating whether the two separate
redox sites acted independently of each other. However, our data
strongly suggest that Cys744 and Cys798 on the NR1 subunit are not
necessary for the redox modulation of NR1/NR2A receptors. What other
residues may be involved in the thiol sensitivity of this receptor
configuration? In a preliminary report (Choi et al., 1997
), the DTT
sensitivity of NR1/NR2A receptors in which five cysteines were mutated
simultaneously (Cys744 and Cys798 on NR1 and Cys87, Cys231, and Cys320
in the amino terminus of NR2A) was evaluated. Even after these
mutations, NMDA-activated currents were still potentiated by DTT,
implying that additional cysteines are involved in redox modulation of
this receptor. Second, logical guesses are the cysteines in NR2A
corresponding to Cys744 and Cys798 in the NR1 subunit, which would
provide a "redundant" redox site in NR1/NR2A receptors. By analogy,
the homologous cysteines in NR2B may impart the residual redox
sensitivity to NR1(C744A, C798A)/NR2B receptors. Although these
cysteines are located on all the NR2 subunits, including NR2C, there
may be structural limitations in an NR1/NR2C receptor, which do not
allow for these two cysteines to be accessible to redox-active
substances. In fact, there are no instances where the NR2A or NR2B
subunits contain homologous cysteines that are not present in NR2C in
regions that face the extracellular milieu (Monyer et al., 1992
).
Clearly, additional work is required to resolve these issues.
Determining the manner in which individual redox sites alter channel
function will likely aid in elucidating how the various domains of NMDA receptor subunits modify channel gating.
We thank Drs. John Horn, Pat Levitt, Jon Johnson, Michael
Cascio, Stuart Arden, and Jeroo Sinor for helpful comments and
discussions, Karen Hartnett for technical assistance, and Dr. Stephen
Traynelis for sharing unpublished data.
Accepted for publication July 8, 1999.
Received for publication March 25, 1999.